CURE: Analysts Strike A Cautious Tone Heading Into 2026
2025-11-26 16:28:37 ET
Introduction
Amid recent worries about the valuation of AI stocks, defensive sectors such as health care have seen an uptick in investor attention. Indeed the unlevered Health Care Select Sector SPDR Fund ETF ( XLV ) is marginally outperforming the SPDR S&P 500 ETF ( SPY ) so far in 2025, while the leveraged Direxion Daily Healthcare Bull 3X Shares ETF ( CURE ) stands out with its 32% year-to-date gain:
Read the full article on Seeking Alpha
For further details see:
CURE: Analysts Strike A Cautious Tone Heading Into 2026NASDAQ: CURE
CURE Trading
-2.11% G/L:
$102.49 Last:
35,117 Volume:
$104.16 Open:



